Summit Therapeutics, Inc. (SMMT)
17.02
-1.60
(-8.59%)
USD |
NASDAQ |
Dec 09, 16:00
17.19
+0.16
(+0.97%)
After-Hours: 17:04
Summit Therapeutics Market Cap: 12.67B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 240.57B |
| CVS Health Corp. | 99.30B |
| UnitedHealth Group, Inc. | 293.17B |
| Iovance Biotherapeutics, Inc. | 893.18M |
| Alnylam Pharmaceuticals, Inc. | 54.85B |
Market Cap Related Metrics
| PEG Ratio | -0.0393 |
| Price to Book Value | 65.92 |
| Price | 17.02 |
| Earnings Yield | -7.29% |
| PEGY Ratio | -0.0393 |